- Home
- LPSN vs OMGA Comparison
LPSN vs OMGA Comparison
Compare LPSN & OMGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPSN
- OMGA
- Stock Information
- Founded
- LPSN 1995
- OMGA 2017
- Country
- LPSN United States
- OMGA United States
- Employees
- LPSN N/A
- OMGA N/A
- Industry
- LPSN EDP Services
- OMGA Biotechnology: Pharmaceutical Preparations
- Sector
- LPSN Technology
- OMGA Health Care
- Exchange
- LPSN Nasdaq
- OMGA Nasdaq
- Market Cap
- LPSN 93.0M
- OMGA 53.6M
- IPO Year
- LPSN 2000
- OMGA 2021
- Fundamental
- Price
- LPSN $0.85
- OMGA $0.84
- Analyst Decision
- LPSN Hold
- OMGA Strong Buy
- Analyst Count
- LPSN 6
- OMGA 5
- Target Price
- LPSN $1.18
- OMGA $9.20
- AVG Volume (30 Days)
- LPSN 1.7M
- OMGA 248.9K
- Earning Date
- LPSN 11-07-2024
- OMGA 11-14-2024
- Dividend Yield
- LPSN N/A
- OMGA N/A
- EPS Growth
- LPSN N/A
- OMGA N/A
- EPS
- LPSN N/A
- OMGA N/A
- Revenue
- LPSN $334,736,000.00
- OMGA $8,095,000.00
- Revenue This Year
- LPSN N/A
- OMGA $181.29
- Revenue Next Year
- LPSN N/A
- OMGA N/A
- P/E Ratio
- LPSN N/A
- OMGA N/A
- Revenue Growth
- LPSN N/A
- OMGA 185.04
- 52 Week Low
- LPSN $0.45
- OMGA $0.75
- 52 Week High
- LPSN $3.98
- OMGA $6.30
- Technical
- Relative Strength Index (RSI)
- LPSN 44.08
- OMGA 41.58
- Support Level
- LPSN $0.77
- OMGA $0.78
- Resistance Level
- LPSN $0.92
- OMGA $0.92
- Average True Range (ATR)
- LPSN 0.06
- OMGA 0.10
- MACD
- LPSN 0.00
- OMGA -0.00
- Stochastic Oscillator
- LPSN 38.45
- OMGA 21.88
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation.. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.
About OMGA Omega Therapeutics Inc.
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. It operates in the U.S.